Brown Stomach Worm (Ostertagia/Teladorsagia)

Brown stomach worm infection, caused by Ostertagia ostertagi in cattle and Teladorsagia circumcincta in sheep and goats, represents one of the most economically significant parasitic diseases of grazing ruminants in temperate climates worldwide. These small, slender nematodes inhabit the abomasum, the true stomach of ruminants, where they disrupt digestive function and cause substantial production losses even in the absence of obvious clinical signs. The common name derives from the brownish coloration of adult worms, distinguishing them from other abomasal parasites.

The distribution of brown stomach worm follows temperate climate patterns, with highest prevalence in regions experiencing cool, moist conditions favorable for larval development and survival on pasture. These parasites dominate the gastrointestinal nematode community in northern Europe, northern North America, southern Australia, New Zealand, and similar climatic zones. In these regions, Ostertagia and Teladorsagia consistently rank as the primary production-limiting parasites, overshadowing other species in economic importance despite causing less dramatic acute disease than blood-feeding parasites like Haemonchus.

The economic impact of brown stomach worm infection manifests primarily through reduced production efficiency rather than mortality. Subclinical infections decrease feed conversion efficiency, reduce weight gains in growing animals, lower milk production in dairy cattle, and impair reproductive performance. These subtle losses accumulate across herds to represent substantial economic drain. Studies estimate that subclinical ostertagiasis alone costs the cattle industry billions of dollars annually worldwide. Clinical disease adds mortality losses and treatment costs to this baseline production impact.

Control of brown stomach worm presents particular challenges due to the parasite's ability to arrest development and survive within the host during unfavorable environmental conditions, a phenomenon called hypobiosis. Larvae ingested in autumn can remain dormant in the abomasal mucosa throughout winter, then resume development simultaneously in spring, causing severe clinical disease known as Type II ostertagiasis. This adaptation ensures parasite survival through periods when environmental conditions would not support pasture-based life cycle stages.

Brown stomach worm infection occurs through ingestion of infective third-stage larvae during grazing on contaminated pastures. Adult female worms residing in the abomasum produce eggs that pass in feces, with each female capable of producing several hundred eggs daily. Within fecal material on pasture, eggs develop through first and second larval stages before third-stage larvae emerge and migrate onto surrounding vegetation. This development requires adequate moisture and moderate temperatures, with the process taking as little as one week under optimal conditions or extending to several weeks in cooler weather.

The life cycle within the host involves intimate association with the gastric glands of the abomasal mucosa. After ingestion, third-stage larvae penetrate gastric glands where they undergo additional development over approximately three weeks before emerging as young adults. This intramural developmental phase causes substantial damage to gastric gland architecture, disrupting production of hydrochloric acid and pepsinogen essential for normal digestion. Damaged glands show cellular changes and functional impairment that persist even after worm elimination.

Environmental and management factors strongly influence brown stomach worm epidemiology. Temperate pastures with adequate rainfall provide ideal habitat for larval development and survival. Continuous grazing of permanent pastures allows cumulative environmental contamination over seasons and years. Stocking density concentrates eggs and larvae in limited areas, increasing infection pressure. Conversely, rotational grazing, mixed-species grazing, and adequate rest periods between grazing events reduce transmission. Young animals in their first grazing season face highest challenge due to naive immunity and high pasture contamination from older herdmates.

Age-related immunity dramatically affects susceptibility and infection outcomes. Calves and lambs in their first grazing season lack protective immunity and develop infections readily upon pasture exposure. With continued exposure, animals gradually develop functional immunity that limits new infections and suppresses existing worm burdens. Adult cattle with several seasons of exposure typically harbor low worm numbers and contribute minimally to pasture contamination. However, stressors including poor nutrition, concurrent disease, or periparturient immunosuppression can compromise this acquired immunity.

Hypobiosis represents a critical adaptation in brown stomach worm biology, particularly in Ostertagia ostertagi affecting cattle. Larvae ingested during autumn, as environmental conditions deteriorate, may arrest development as early fourth-stage larvae within gastric glands rather than completing development. These inhibited larvae can persist for months without causing pathology. When conditions trigger resumption of development, typically in late winter or spring, massive simultaneous emergence of previously arrested larvae causes severe mucosal damage. This synchronous emergence characterizes Type II ostertagiasis, distinguishing it from Type I disease caused by ongoing development of recently ingested larvae.

Early warning signs of brown stomach worm infection are subtle and easily attributed to other causes, making detection challenging without deliberate monitoring. Reduced weight gain in growing animals often represents the first detectable impact, with affected cattle or sheep failing to achieve expected growth rates despite adequate nutrition. Feed efficiency declines as damaged abomasal function impairs digestion and nutrient absorption. Rough, dull hair coat develops in cattle, reflecting general unthriftiness. These nonspecific signs frequently pass unnoticed in extensively managed herds.

Clinical symptoms become more apparent as worm burdens increase or when Type II disease develops. Profuse watery diarrhea is the hallmark clinical sign, typically bright green and foul-smelling in cattle, staining the hindquarters and tail. The diarrhea results from elevated abomasal pH impairing protein digestion, allowing undigested protein to reach the lower gut where bacterial fermentation produces the characteristic foul odor. Reduced appetite accompanies digestive dysfunction, further compromising nutritional status. Progressive weight loss continues despite maintained or increased feed availability.

Behavioral changes accompany physical symptoms in clinically affected animals. Reduced activity and depression become evident as animals spend more time lying down and less time grazing. Affected animals may separate from the herd or flock, lagging behind during movement. Rumination patterns change, with reduced cud chewing reflecting decreased feed intake. In severe cases, animals become weak and reluctant to rise, spending extended periods recumbent. These behavioral changes often precede the most severe physical symptoms.

Physical examination findings in clinical ostertagiasis or teladorsagiasis include poor body condition despite adequate nutritional availability. Submandibular edema, or bottle jaw, may develop in severe chronic cases due to protein loss, though this sign is more typical of blood-feeding parasites. Dehydration from diarrhea produces dry mucous membranes, sunken eyes, and reduced skin elasticity. Auscultation may reveal increased gut sounds associated with diarrhea. Anemia is typically mild or absent, distinguishing brown stomach worm from Haemonchus infection.

Symptom progression differs between Type I and Type II ostertagiasis. Type I disease develops gradually during the grazing season as animals accumulate worm burdens through ongoing larval ingestion. Symptoms increase progressively with worm numbers, and clinical disease typically peaks in late summer or autumn. Type II disease presents as acute or peracute onset of severe symptoms, often affecting multiple animals simultaneously, typically occurring in late winter or early spring when inhibited larvae resume development en masse. The sudden, severe presentation of Type II disease frequently surprises producers who observed no problems in preceding months.

Emergency symptoms warranting immediate veterinary attention include severe dehydration from profuse diarrhea, recumbency with inability to rise, and signs of systemic shock. Multiple animals developing acute diarrhea simultaneously suggests Type II ostertagiasis requiring urgent herd-level intervention. Animals showing signs of protein-losing enteropathy with edema and severe weakness require intensive supportive care alongside anthelmintic treatment. Mortality can occur in severe cases, particularly in Type II disease when massive larval emergence overwhelms the host's capacity to compensate.

Clinical examination provides initial diagnostic direction but cannot definitively distinguish brown stomach worm from other causes of diarrhea and weight loss in ruminants. History of pasture exposure, age group affected, and seasonal timing provide important context. The combination of profuse watery diarrhea, weight loss despite adequate nutrition, and rough coat in grazing cattle strongly suggests ostertagiasis. In sheep and goats, similar signs point toward teladorsagiasis, though concurrent Haemonchus infection must also be considered. Physical findings of dehydration and poor condition support but do not confirm parasitic cause.

Fecal egg counts remain a primary diagnostic tool, though interpretation requires understanding of limitations. The modified McMaster technique quantifies eggs per gram of feces, providing a standardized measure. However, egg counts have important limitations for brown stomach worm diagnosis. During Type II ostertagiasis, clinical disease results from emerging larvae and immature adults not yet producing eggs, so severely affected animals may have low or zero egg counts. Additionally, host immunity suppresses egg production in chronically infected adults, potentially masking significant worm burdens. Negative egg counts do not rule out brown stomach worm infection.

Plasma pepsinogen testing provides a valuable diagnostic tool for ostertagiasis in cattle, reflecting abomasal damage caused by developing larvae. Pepsinogen normally remains contained within gastric glands, but mucosal damage from larval emergence allows leakage into circulation. Elevated plasma pepsinogen concentrations correlate with recent larval emergence and abomasal pathology. Peak elevations occur during active Type I disease and at the onset of Type II disease. This test helps diagnose ostertagiasis when fecal egg counts are unreliable and provides objective evidence of abomasal damage.

Necropsy examination of fatal cases or sacrificed animals provides definitive diagnosis, allowing direct visualization and counting of worms in the abomasum. Total worm counts distinguish clinical from subclinical infection levels. Species identification confirms Ostertagia or Teladorsagia as the cause. Characteristic Morocco leather appearance of the abomasal mucosa, with raised nodules representing damaged gastric glands, provides gross pathological evidence even if worms are not immediately visible. Histopathology demonstrates glandular damage, cellular infiltration, and larval stages within tissues.

Emergency treatment of severely affected animals addresses immediate life-threatening conditions before or alongside anthelmintic therapy. Aggressive fluid therapy corrects dehydration from diarrhea, using intravenous or subcutaneous routes depending on severity. Electrolyte replacement addresses losses through diarrhea. Nutritional support begins with easily digestible, high-quality feeds once acute diarrhea subsides. Anti-inflammatory medications may reduce abomasal inflammation and discomfort. In recumbent animals, nursing care including assistance with rising, soft bedding, and protection from weather supports survival during recovery.

Anthelmintic selection for brown stomach worm considers efficacy against arrested larvae during Type II disease. The three major drug classes show varying activity against inhibited stages. Macrocyclic lactones, particularly moxidectin, demonstrate the best efficacy against hypobiotic larvae. Benzimidazoles including fenbendazole and albendazole at standard doses show variable activity against arrested stages, with some products labeled for extended dosing to address inhibited larvae. Levamisole and other imidazothiazoles have limited activity against arrested larvae. Drug selection must also consider resistance status in the specific herd, as resistance has been documented to all major classes.

Strategic treatment timing optimizes brown stomach worm control while preserving anthelmintic efficacy. Treating cattle at housing in autumn, before the majority of ingested larvae enter hypobiosis, prevents accumulation of arrested larvae responsible for Type II disease. Spring treatment targeting any larvae that escaped autumn treatment and are resuming development provides additional protection. Mid-season treatments during the grazing period may be indicated when pasture contamination is high or when strategic treatments were missed. Coordination of treatment with pasture moves maximizes benefit by preventing immediate reinfection.

Supportive care accelerates recovery from clinical ostertagiasis or teladorsagiasis. High-quality nutrition supports repair of damaged abomasal mucosa and restoration of body condition. Temporary housing on dry lots removes animals from continued parasite exposure during recovery. Monitoring body weight and condition tracks recovery progress. Repeat fecal egg counts two to three weeks post-treatment confirm efficacy. Animals failing to respond clinically despite appropriate treatment require investigation for resistant worm populations or concurrent disease.

Herd-level treatment protocols balance disease control with resistance management. Whole-herd treatments at strategic times, such as housing, remain appropriate when timed to interrupt the parasite life cycle. However, routine treatments without diagnostic indication accelerate resistance. Targeted treatments based on production parameters, such as treating cattle below threshold weight gains, direct treatment to animals most likely to benefit. Selective treatment approaches developed for small ruminants, including FAMACHA, have limited applicability for brown stomach worm since anemia is not a feature. Alternative selection criteria based on body condition or fecal egg counts may guide targeted approaches.

Economic considerations influence treatment decisions in commercial cattle and sheep operations. The cost-benefit of treatment depends on magnitude of production losses, drug costs, and treatment labor. Studies consistently demonstrate positive returns on strategic anthelmintic treatment for ostertagiasis in cattle, with treated animals showing improved weight gains exceeding treatment costs. However, treatment of adult cattle with established immunity rarely shows economic benefit. Young stock in their first and second grazing seasons represent the primary treatment targets. Cull decisions for chronically affected animals weigh treatment costs and expected recovery against market value.

Recovery timelines following brown stomach worm treatment depend on initial severity and extent of abomasal damage. Worm elimination occurs within days of effective anthelmintic treatment, with reduction in fecal egg output confirming drug efficacy within two to three weeks. However, restoration of normal abomasal function requires regeneration of damaged gastric glands, a process taking several weeks. Clinical improvement in diarrhea typically occurs within one to two weeks as abomasal pH normalizes and protein digestion improves. Full recovery of body condition may require one to three months depending on initial weight loss.

Post-treatment care and monitoring ensure recovery proceeds satisfactorily and detect treatment failures. Fecal egg count reduction testing compares pre-treatment and post-treatment egg counts to confirm efficacy, with reductions below 95% suggesting resistance. Clinical monitoring tracks resolution of diarrhea and improvement in body condition. Weight monitoring, particularly in growing cattle or sheep, documents return to normal growth rates. Animals failing to improve clinically despite confirmed egg count reduction may have concurrent disease or permanent abomasal damage from severe infection.

Prognostic factors influencing recovery include severity at treatment, age, nutritional status, and extent of mucosal damage. Animals treated early with mild to moderate infection typically recover completely. Severe Type II ostertagiasis causing extensive abomasal damage may result in permanent digestive impairment even after successful worm elimination. Young animals generally recover more completely than older animals with the same degree of damage. Adequate nutrition during recovery supports tissue repair and condition restoration.

Return to production considerations guide post-recovery management. Growing animals should demonstrate consistent weight gains before marketing. Breeding animals should recover fully before demanding reproductive efforts. Withdrawal periods for meat and milk must be observed strictly, with times varying by drug and product. Animals returning to pasture face reinfection risk, so timing of turnout relative to seasonal larval availability influences outcomes. Moving recovered animals to pastures with low contamination levels, if available, maximizes benefit of treatment.

No vaccines are available for brown stomach worm prevention in any species, placing control responsibility entirely on management strategies. Research on Ostertagia vaccines has been ongoing for decades, with some experimental products showing promise but none reaching commercial availability. Until vaccines emerge, integrated approaches combining grazing management, strategic treatment, and breeding for resistance provide the foundation for sustainable control.

Biosecurity measures focus on managing pasture contamination rather than excluding the parasite, as brown stomach worm is essentially ubiquitous on temperate pastures. Introduction of heavily parasitized animals increases pasture contamination, so quarantine treatment of new arrivals limits this amplification. However, complete exclusion of the parasite is neither possible nor necessarily desirable, as exposure is needed to stimulate protective immunity. The goal is managing exposure levels rather than eliminating the parasite.

Nutritional management supports immune development and helps animals tolerate moderate infections without clinical disease. Adequate protein intake is particularly important for growing animals developing immunity during their first grazing season. Energy sufficiency ensures resources are available for both immune responses and continued production. Strategic supplementation during periods of high parasite challenge can reduce production impacts. Well-nourished animals develop immunity more effectively and express that immunity more consistently.

Grazing management provides the most powerful tool for reducing brown stomach worm transmission. Rotational grazing with adequate rest periods allows larval mortality before animals return to pastures. Rest periods of 60 to 90 days significantly reduce larval contamination in temperate conditions. Leader-follower systems, where immune adult cattle graze before susceptible young stock, reduce larval intake by calves. Mixed grazing with sheep and cattle reduces species-specific parasite buildup, as Ostertagia ostertagi poorly infects sheep while Teladorsagia circumcincta poorly infects cattle. Conservation of some pastures as safe grazing for calves after weaning, using land that adult cattle have not grazed during the current season, limits first-season exposure.

Strategic anthelmintic programs integrated with grazing management optimize control while minimizing resistance selection. Housing treatments in autumn, as previously discussed, interrupt hypobiosis. Turn-out treatments in spring, when combined with movement to safe pasture, provide clean animals on clean ground. Mid-season treatments should be based on monitoring rather than calendar scheduling. Maintaining refugia by leaving some animals untreated, or by turning treated animals onto contaminated rather than clean pastures, preserves susceptible parasite genetics in the population.

Daily management of cattle and sheep at risk for brown stomach worm infection requires awareness of subtle production impacts that may not be obvious on casual observation. Regular monitoring of weight gains in growing animals, compared to expected performance for genetics and nutrition, identifies shortfalls potentially attributable to parasitism. Observation of fecal consistency across the herd detects diarrhea before severe clinical disease develops. Noting animals with poor coat condition or lagging body condition scores flags individuals for closer evaluation. Consistent daily observation creates baseline familiarity that allows early detection of changes.

Housing and environmental management options vary with production system and climate. Cattle systems using winter housing can leverage the housing period for strategic treatment and breaking transmission cycles. Permanent indoor housing, while eliminating pasture exposure, is uncommon and economically impractical for most cattle operations. For sheep, similar principles apply where housing is practiced. Management of feedlots and sacrifice paddocks, where animals concentrate, requires attention to preventing fecal-oral transmission even in non-pasture settings.

Herd health programs integrate brown stomach worm management with other health priorities. Scheduled monitoring, typically including fecal egg counts at turnout, mid-season, and housing, tracks infection dynamics through the grazing season. Integration with other handling events improves efficiency. Growth monitoring tied to parasite diagnostics identifies production impacts attributable to parasitism. Veterinary consultation ensures appropriate drug selection considering local resistance patterns. Recording outcomes allows program refinement over time.

Record keeping provides the foundation for evidence-based parasite management. Individual animal weights tracked over time quantify growth impacts. Fecal egg count records by age group and season reveal infection dynamics. Treatment records including drug, dose, and timing support resistance monitoring and withdrawal compliance. Economic records connecting parasite management costs with production outcomes justify program investments. Analysis of accumulated records identifies patterns guiding program improvements.

Economic optimization drives commercial brown stomach worm management decisions. The substantial subclinical production losses from ostertagiasis justify investment in control programs that would not be warranted if only clinical disease were considered. Studies demonstrate positive returns on investment for strategic control programs in first-season grazing cattle. However, economic analysis must be operation-specific, considering local conditions, cattle prices, drug costs, and labor availability. Balancing control costs against production benefits while considering resistance sustainability requires ongoing evaluation.

Breed differences in susceptibility to brown stomach worm are relatively modest compared to other production traits, with management and exposure history generally having greater influence than genetics. Among cattle breeds, British breeds including Angus and Hereford show comparable susceptibility to Continental breeds. Bos indicus influenced cattle, including Brahman and Brahman crosses, demonstrate some resistance advantage that may be more pronounced for other parasites than for Ostertagia specifically. Dairy breeds face particular challenges due to production stress and management intensity. Within-breed variation substantially exceeds between-breed differences.

Production type and system influence brown stomach worm exposure patterns and management options. Beef cattle in extensive grazing systems face continuous exposure during the grazing season but typically have options for pasture rotation. Dairy cattle in intensive grazing systems may face very high stocking densities and limited pasture rest options, increasing challenge. Stocker and backgrounder operations introducing cattle from various sources to common pastures face high and variable exposure. Finishing cattle in feedlots leave pasture exposure behind but may carry worm burdens acquired during grazing phases.

Genetic selection for brown stomach worm resistance is possible but less developed than for some other parasite species. Heritability estimates for fecal egg counts, the primary selection trait, range from 0.2 to 0.4, indicating moderate response to selection. Some beef breeds, particularly in New Zealand and Australia, have incorporated parasite resistance into breeding programs. However, selection for Ostertagia resistance specifically has received less attention than selection for resistance to mixed trichostrongylid infection. Future breeding programs may increasingly incorporate parasite resistance alongside production and other health traits as genomic tools make multi-trait selection more feasible.

Brown stomach worm commonly occurs alongside other gastrointestinal nematodes in grazing ruminants. In cattle, Cooperia species share similar epidemiology and frequently co-infect animals. In sheep and goats, Haemonchus contortus, Trichostrongylus species, and Nematodirus battus commonly accompany Teladorsagia. Mixed infections may have additive or synergistic impacts on host health and production. Diagnostic approaches must account for multiple species, and treatment selection should address the full spectrum of parasites present. Fecal egg counts reflect total strongylid output without distinguishing species.

Several conditions produce clinical signs similar to brown stomach worm infection, requiring careful differential diagnosis. Johne's disease causes chronic diarrhea and weight loss in adult cattle, diagnosed through fecal culture, PCR, or serology. Salmonellosis produces acute diarrhea, typically with fever and systemic illness distinguishing it from parasitic causes. Bovine viral diarrhea can cause diarrhea and ill-thrift. Copper deficiency produces diarrhea and poor condition in cattle and sheep. Dietary factors including lush pasture or moldy feed can cause transient diarrhea. Complete diagnostic workup including fecal examination, blood work, and potentially necropsy distinguishes these possibilities.

Complications of severe brown stomach worm infection include secondary bacterial infection of damaged abomasal mucosa. Protein-losing gastroenteropathy may result from severe mucosal damage, causing hypoproteinemia and edema. Prolonged inappetence leads to energy deficit and potential ketosis in pregnant animals. Growth stunting during critical developmental periods may have permanent effects even after successful treatment. Immunosuppression from malnutrition increases susceptibility to other infectious diseases. Economic complications include delayed marketing, reduced sale weights, and increased treatment costs. Death occurs in severe cases, particularly untreated Type II ostertagiasis.